Publications by authors named "Samira Garonzik"

Claim this Profile
A
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
Sean D Pokorney, Glenn M Chertow, Hussein R Al-Khalidi, Dianne Gallup, Pat Dignacco, Samira Garonzik

Circulation· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment.
Charles E Frost, Van Ly, Samira M Garonzik

Drugs R D· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban Single-Dose Pharmacokinetics, Bioavailability, Renal Clearance, and Pharmacodynamics Following Intravenous and Oral Administration.
Charles Frost, Samira Garonzik, Andrew Shenker, Yu Chen Barrett, Frank LaCreta

Clin Pharmacol Drug Dev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
Mohammed N Meah, Jennifer Raftis, Simon J Wilson, Vidya Perera, Samira M Garonzik

Arterioscler Thromb Vasc Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
John W Stanifer, Sean D Pokorney, Glenn M Chertow, Stefan H Hohnloser, Daniel M Wojdyla, Samira Garonzik

Circulation· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study.
Samira Garonzik, Wonkyung Byon, Elsa Myers, Xiodong Li, David Marchisin

Am J Cardiovasc Drugs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review.
Wonkyung Byon, Samira Garonzik, Rebecca A Boyd, Charles E Frost

Clin Pharmacokinet· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition.
Hong Shen, Lisa Christopher, Yurong Lai, Jiachang Gong, Hamza Kandoussi, Samira Garonzik

Drug Metab Dispos· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.
Simon J Wilson, Fraz A Ismat, Zhaoqing Wang, Michael Cerra, Hafid Narayan, Samira Garonzik

Arterioscler Thromb Vasc Biol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients.
Alan Forrest, Samira M Garonzik, Visanu Thamlikitkul, Evangelos J Giamarellos-Bourboulis, David L Paterson

Antimicrob Agents Chemother· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Corona and Cattaneo.
Roger L Nation, Samira M Garonzik, Visanu Thamlikitkul, Evangelos J Giamarellos-Bourboulis, Alan Forrest

Clin Infect Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach.
Samira M Garonzik, Justin R Lenhard, Alan Forrest, Patricia N Holden, Jϋrgen B Bulitta

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Justin R Lenhard, Visanu Thamlikitkul, Fernanda P Silveira, Samira M Garonzik, Xun Tao

J Antimicrob Chemother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing guidance for intravenous colistin in critically-ill patients.
Roger L Nation, Samira M Garonzik, Visanu Thamlikitkul, Evangelos J Giamarellos-Bourboulis, Alan Forrest

Clin Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UHPLC-MS/MS bioanalysis of urinary DHEA, cortisone and their hydroxylated metabolites as potential biomarkers for CYP3A-mediated drug-drug interactions.
Naiyu Zheng, Lisa J Christopher, Xuewen Ma, Qin C Ji, Adela Buzescu, Samira M Garonzik

Bioanalysis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Roger L Nation, Samira M Garonzik, Jian Li, Visanu Thamlikitkul, Evangelos J Giamarellos-Bourboulis

Clin Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease.
Gauri G Rao, Neang S Ly, Curtis E Haas, Samira Garonzik, Alan Forrest

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.
Julie B Dumond, Melanie R Nicol, Racheal N Kendrick, Samira M Garonzik, Kristine B Patterson

Clin Pharmacokinet· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection.
John S Bradley, Samira Merali Garonzik, Alan Forrest, Sujata M Bhavnani

Pediatr Infect Dis J· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis